Clinical utility of PET/CT in lymphoma

Carmel G. Cronin, Ronan T Swords, Mylene T. Truong, Chitra Viswanathan, Eric Rohren, Francis J. Giles, Michael O'Dwyer, John F. Bruzzi

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

OBJECTIVE. The purpose of this review is to assist interpreting radiologists in becoming familiar with the role of PET/CT in baseline staging and therapeutic response assessment in the management of lymphoma, in becoming aware of imaging pitfalls, and in understanding the natural behavior of lymphoma and the therapeutic options. CONCLUSION. Therapeutic strategies for the management of lymphoma are constantly being refined to improve long-term survival with the lowest risk of toxicity to the patient. PET/CT is accurate for baseline staging and yields important prognostic information for determining the most appropriate initial treatment. Used for evaluation of treatment response, PET/CT can depict residual viable malignant lesions with greater accuracy than can other imaging techniques. The findings thereby influence decisions about the need for additional or alternative treatment.

Original languageEnglish
JournalAmerican Journal of Roentgenology
Volume194
Issue number1
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Lymphoma
Therapeutics
Survival

Keywords

  • Lymphoma
  • PET/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Cronin, C. G., Swords, R. T., Truong, M. T., Viswanathan, C., Rohren, E., Giles, F. J., ... Bruzzi, J. F. (2010). Clinical utility of PET/CT in lymphoma. American Journal of Roentgenology, 194(1). https://doi.org/10.2214/AJR.09.2637

Clinical utility of PET/CT in lymphoma. / Cronin, Carmel G.; Swords, Ronan T; Truong, Mylene T.; Viswanathan, Chitra; Rohren, Eric; Giles, Francis J.; O'Dwyer, Michael; Bruzzi, John F.

In: American Journal of Roentgenology, Vol. 194, No. 1, 01.01.2010.

Research output: Contribution to journalArticle

Cronin, CG, Swords, RT, Truong, MT, Viswanathan, C, Rohren, E, Giles, FJ, O'Dwyer, M & Bruzzi, JF 2010, 'Clinical utility of PET/CT in lymphoma', American Journal of Roentgenology, vol. 194, no. 1. https://doi.org/10.2214/AJR.09.2637
Cronin CG, Swords RT, Truong MT, Viswanathan C, Rohren E, Giles FJ et al. Clinical utility of PET/CT in lymphoma. American Journal of Roentgenology. 2010 Jan 1;194(1). https://doi.org/10.2214/AJR.09.2637
Cronin, Carmel G. ; Swords, Ronan T ; Truong, Mylene T. ; Viswanathan, Chitra ; Rohren, Eric ; Giles, Francis J. ; O'Dwyer, Michael ; Bruzzi, John F. / Clinical utility of PET/CT in lymphoma. In: American Journal of Roentgenology. 2010 ; Vol. 194, No. 1.
@article{2c16cece8a5d42fc91ad07067235f384,
title = "Clinical utility of PET/CT in lymphoma",
abstract = "OBJECTIVE. The purpose of this review is to assist interpreting radiologists in becoming familiar with the role of PET/CT in baseline staging and therapeutic response assessment in the management of lymphoma, in becoming aware of imaging pitfalls, and in understanding the natural behavior of lymphoma and the therapeutic options. CONCLUSION. Therapeutic strategies for the management of lymphoma are constantly being refined to improve long-term survival with the lowest risk of toxicity to the patient. PET/CT is accurate for baseline staging and yields important prognostic information for determining the most appropriate initial treatment. Used for evaluation of treatment response, PET/CT can depict residual viable malignant lesions with greater accuracy than can other imaging techniques. The findings thereby influence decisions about the need for additional or alternative treatment.",
keywords = "Lymphoma, PET/CT",
author = "Cronin, {Carmel G.} and Swords, {Ronan T} and Truong, {Mylene T.} and Chitra Viswanathan and Eric Rohren and Giles, {Francis J.} and Michael O'Dwyer and Bruzzi, {John F.}",
year = "2010",
month = "1",
day = "1",
doi = "10.2214/AJR.09.2637",
language = "English",
volume = "194",
journal = "AJR. American journal of roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "1",

}

TY - JOUR

T1 - Clinical utility of PET/CT in lymphoma

AU - Cronin, Carmel G.

AU - Swords, Ronan T

AU - Truong, Mylene T.

AU - Viswanathan, Chitra

AU - Rohren, Eric

AU - Giles, Francis J.

AU - O'Dwyer, Michael

AU - Bruzzi, John F.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - OBJECTIVE. The purpose of this review is to assist interpreting radiologists in becoming familiar with the role of PET/CT in baseline staging and therapeutic response assessment in the management of lymphoma, in becoming aware of imaging pitfalls, and in understanding the natural behavior of lymphoma and the therapeutic options. CONCLUSION. Therapeutic strategies for the management of lymphoma are constantly being refined to improve long-term survival with the lowest risk of toxicity to the patient. PET/CT is accurate for baseline staging and yields important prognostic information for determining the most appropriate initial treatment. Used for evaluation of treatment response, PET/CT can depict residual viable malignant lesions with greater accuracy than can other imaging techniques. The findings thereby influence decisions about the need for additional or alternative treatment.

AB - OBJECTIVE. The purpose of this review is to assist interpreting radiologists in becoming familiar with the role of PET/CT in baseline staging and therapeutic response assessment in the management of lymphoma, in becoming aware of imaging pitfalls, and in understanding the natural behavior of lymphoma and the therapeutic options. CONCLUSION. Therapeutic strategies for the management of lymphoma are constantly being refined to improve long-term survival with the lowest risk of toxicity to the patient. PET/CT is accurate for baseline staging and yields important prognostic information for determining the most appropriate initial treatment. Used for evaluation of treatment response, PET/CT can depict residual viable malignant lesions with greater accuracy than can other imaging techniques. The findings thereby influence decisions about the need for additional or alternative treatment.

KW - Lymphoma

KW - PET/CT

UR - http://www.scopus.com/inward/record.url?scp=74749105067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74749105067&partnerID=8YFLogxK

U2 - 10.2214/AJR.09.2637

DO - 10.2214/AJR.09.2637

M3 - Article

VL - 194

JO - AJR. American journal of roentgenology

JF - AJR. American journal of roentgenology

SN - 0361-803X

IS - 1

ER -